Metabolic improvement after intervention focusing on personal understanding in type 2 diabetes (original) (raw)
Related papers
Metabolic Control of Adults With Type 2 Diabetes Mellitus Through Education and Counseling
Journal of Nursing Scholarship, 2006
Purpose: To test the efficacy of a controlled nursing intervention focused on education and counseling to improve metabolic control of adults diagnosed with diabetes mellitus type 2 in (DMT2) ambulatory care.Design: A quasi-experimental design with repeated measures was selected. A sample of 45 subjects participated, of which 25 were in the experimental group, and 20 in the comparison group. Measures were taken at 0, 3, 6, 9, and 12 months, including glycosylatedhemoglobin (HbA1c), psychosocial, and clinical variables.Findings: Results showed a significant decrease in HbA1c in the experimental group, as well as positive effects of self-care agency, adaptation, and barriers to treatment (plus one interaction) on the HbA1c levels and on the scores of self-care actions.Conclusions: The counseling and educational model applied in the intervention was effective to improve the metabolic control of diabetic patients in the experimental group. Self-care agency, adaptation, and barriers were predictors of self-care measures and level of HbA1c.
INFLUENCE OF DIABETIC EDUCATION ON PATIENT WELL-BEING AND METABOLIC CONTROL
2004
The aim of this study was to evaluate the possible influence of a structured teaching program for interactive group education of diabetic patients on their overall well-being and metabolic control. The study included 110 insulin-treated diabetic patients. They were followed for one year after a 4-day structured teaching program performed at University Department of Endocrinology, Diabetes and Metabolic Disorders, School of Medicine in Skopje. At re-education sessions one year after education we noticed significant improvement in metabolic control, HbA 1c decreased from 9.2±1.3 to 7.7±1.8% (p<0.0005), diabetes related knowledge improved from 49.1±16.8 to 85.4±14.3% (p<0.05), and patient overall wellbeing improved from 46.6±8.3 to 54.8±5.9 (p<0.05) due to reduction of depression (p<0.003) and anxiety (p<0.004), and increase in energy (p<0.0006) and well-being (p<0.002). Study results confirmed the improvement of overall well-being, metabolic control and diabetes related knowledge in insulintreated diabetic patients after a structured education program.
2018
1. Department of Health Education and Health Promotion, School of Health, Bushehr University of Medical Sciences, Bushehr, Iran. 2. Department of Public Health, School of Health, Qom University of Medical Sciences and Health Services, Qom, Iran. 3. Department of Health Education and Health Services, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran. 4. Department of Public Health, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran. 5. Department of Social Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Research Paper: Effects of an Educational Intervention on Self-Care and Metabolic Control in Patients With Type II Diabetes
Management and Education in Patients with Diabetes Mellitus
Medical & Clinical Reviews
Patients with Diabetes Mellitus (DM) can actively participate in the management of this disease, with therapeutic education playing an essential role in the optimization of knowledge, resources and skills required to achieve targets of metabolic control, reduce the onset of acute and chronic complications, and preserve quality of life. In this context, the management of DM becomes a holistic endeavor, by promoting the reasonable use of therapeutic resources by the patient's themselvesinvolving self-management and self-efficacy, their families and their communities, aiming to obtain optimum results. This review summarizes current literature on the active patient-centered management of DM, in order to promote an improvement in these therapeutic goals.
British Medical Journal, 2008
Objective To evaluate the effectiveness of a structured group education programme on biomedical, psychosocial, and lifestyle measures in people with newly diagnosed type 2 diabetes. Design Multicentre cluster randomised controlled trial in primary care with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United Kingdom. Participants 824 adults (55% men, mean age 59.5 years). Intervention A structured group education programme for six hours delivered in the community by two trained healthcare professional educators compared with usual care. Main outcome measures Haemoglobin A 1c levels, blood pressure, weight, blood lipid levels, smoking status, physical activity, quality of life, beliefs about illness, depression, and emotional impact of diabetes at baseline and up to 12 months. Main results Haemoglobin A 1c levels at 12 months had decreased by 1.49% in the intervention group compared with 1.21% in the control group. After adjusting for baseline and cluster, the difference was not significant: 0.05% (95% confidence interval −0.10% to 0.20%). The intervention group showed a greater weight loss: −2.98 kg (95% confidence interval −3.54 to −2.41) compared with 1.86 kg (−2.44 to −1.28), P=0.027 at 12 months. The odds of not smoking were 3.56 (95% confidence interval 1.11 to 11.45), P=0.033 higher in the intervention group at 12 months. The intervention group showed significantly greater changes in illness belief scores (P=0.001); directions of change were positive indicating greater understanding of diabetes. The intervention group had a lower depression score at 12 months: mean difference was −0.50 (95% confidence interval −0.96 to −0.04); P=0.032. A positive association was found between change in perceived personal responsibility and weight loss at 12 months (β=0.12; P=0.008). Conclusion A structured group education programme for patients with newly diagnosed type 2 diabetes resulted in greater improvements in weight loss and smoking cessation and positive improvements in beliefs about illness but no difference in haemoglobin A 1c levels up to 12 months after diagnosis. Trial registration Current Controlled Trials ISRCTN17844016.
The Diabetes Educator, 2020
J.K.B reports being a past chair of the Certification Board for Diabetes Care and Education, is the program chair for the Association of Diabetes Care & Education Specialists annual meeting, and has been a consultant to Joslin Diabetes Center. M.M.F. is on an advisory board of Eli Lilly. D.H. is the treasurer for the American Academy of Nurse Practitioners Certification Board of Commissioners and vice president of the American Nurse Practitioner Foundation. A.H.-F. reports receiving an honorarium from ADA as an Education Recognition Program auditor and is a participant in a speakers bureau sponsored by Abbott Diabetes Care and Xeris. D.I. reports being a participant in a speakers bureau/consultant for Xeris Pharmaceuticals, Novo Nordisk, Dexcom, and Lifescan. M.D.M. reports being a paid consultant of Diabetes-What to Know, Arkray, and DayTwo. A.N. reports being a participant in speakers bureaus sponsored by Boehringer Ingelheim, Novo Nordisk, and Xeris. L.M.S. reports research grant funding from Becton Dickinson. S.U. has received honoraria from ADA. No other potential conflicts of interest relevant to this article were reported.